GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LigaChem Biosciences Inc (XKRX:141080) » Definitions » Cyclically Adjusted PS Ratio

LigaChem Biosciences (XKRX:141080) Cyclically Adjusted PS Ratio : 48.46 (As of Jun. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is LigaChem Biosciences Cyclically Adjusted PS Ratio?

As of today (2024-06-08), LigaChem Biosciences's current share price is ₩69000.00. LigaChem Biosciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩1,423.90. LigaChem Biosciences's Cyclically Adjusted PS Ratio for today is 48.46.

The historical rank and industry rank for LigaChem Biosciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:141080' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 26.64   Med: 34.86   Max: 59.98
Current: 44.74

During the past years, LigaChem Biosciences's highest Cyclically Adjusted PS Ratio was 59.98. The lowest was 26.64. And the median was 34.86.

XKRX:141080's Cyclically Adjusted PS Ratio is ranked worse than
91.07% of 504 companies
in the Biotechnology industry
Industry Median: 5.47 vs XKRX:141080: 44.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LigaChem Biosciences's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩1,081.972. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩1,423.90 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


LigaChem Biosciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for LigaChem Biosciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LigaChem Biosciences Cyclically Adjusted PS Ratio Chart

LigaChem Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 36.71 49.35

LigaChem Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.50 28.99 28.61 49.35 52.53

Competitive Comparison of LigaChem Biosciences's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, LigaChem Biosciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LigaChem Biosciences's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LigaChem Biosciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LigaChem Biosciences's Cyclically Adjusted PS Ratio falls into.



LigaChem Biosciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LigaChem Biosciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=69000.00/1423.9
=48.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LigaChem Biosciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, LigaChem Biosciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1081.972/118.8477*118.8477
=1,081.972

Current CPI (Mar. 2024) = 118.8477.

LigaChem Biosciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 27.311 99.353 32.670
201409 9.153 99.608 10.921
201412 12.278 99.098 14.725
201503 7.128 99.720 8.495
201506 12.438 100.050 14.775
201509 12.252 100.110 14.545
201512 82.805 100.220 98.196
201603 257.879 100.560 304.777
201606 226.421 100.790 266.987
201609 209.819 101.460 245.777
201612 213.136 101.560 249.416
201703 276.252 102.850 319.221
201706 276.344 102.610 320.075
201709 279.274 103.490 320.718
201712 276.638 102.990 319.233
201803 333.028 104.100 380.208
201806 311.397 104.130 355.410
201809 311.472 105.650 350.381
201812 259.187 104.350 295.197
201903 464.281 104.490 528.077
201906 364.138 104.880 412.633
201909 1,313.953 105.200 1,484.413
201912 372.464 105.120 421.104
202003 135.248 105.540 152.302
202006 842.374 104.870 954.651
202009 233.174 106.200 260.943
202012 1,113.908 105.765 1,251.689
202103 220.098 107.357 243.655
202106 190.593 107.579 210.558
202109 182.070 108.759 198.959
202112 738.586 109.676 800.348
202203 239.637 111.806 254.730
202206 482.315 114.083 502.460
202209 101.552 114.831 105.104
202212 242.215 115.200 249.884
202303 269.706 116.550 275.024
202306 458.149 117.140 464.828
202309 196.968 119.111 196.532
202312 267.422 118.848 267.422
202403 1,081.972 118.848 1,081.972

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LigaChem Biosciences  (XKRX:141080) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LigaChem Biosciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of LigaChem Biosciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LigaChem Biosciences (XKRX:141080) Business Description

Traded in Other Exchanges
N/A
Address
8-26 Munpyeongseo-ro, Daedeok-gu, Daejeon, KOR, 34302
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

LigaChem Biosciences (XKRX:141080) Headlines

No Headlines